Agentforce KPIs strengthen, but lack of cRPO breakout still caps the near-term share price
AI summary card
Agentforce KPIs strengthen, but lack of cRPO breakout still caps the near-term share price
Morgan Stanley maintains Overweight on Salesforce and its $287 target price, believing AI and the data platform offer positive risk/reward, but second-half subscription revenue reacceleration still needs to materialize.
- Agentforce ARR reached $1.2 billion, up 205% year over year; AWUs grew 111% quarter over quarter, and token usage increased 152% quarter over quarter.
- Q1 cRPO grew 14% year over year, or 13% in constant currency, essentially only meeting guidance, marking a second straight quarter without upside surprise.
- Non-GAAP operating margin was 34.8%, up 250 basis points year over year and 140 basis points above market expectations.
- The company executed a $25 billion accelerated share repurchase, reducing diluted share count by about 10% year over year.
- The FY27 subscription growth target remains around 12%, including about 8% organic constant-currency growth, and management still expects acceleration in the second half.
Report interpretation
Overview
The report reviews Salesforce's FY1Q27 results. The core conclusion is that AI/data-related metrics such as Agentforce, Data 360, and Slack are accelerating, but these leading usage indicators have not yet translated into a clear improvement in cRPO and bookings growth. Therefore, the near-term stock price may remain constrained; however, at a valuation of 11x EV/CY27 FCF, risk/reward remains favorable if organic subscription revenue reaccelerates in the second half as management expects.
Core views
Morgan Stanley believes Salesforce's fundamentals show a "two-sided" picture: on one hand, Agentforce ARR has exceeded $1 billion, AWUs and token usage are growing rapidly, Slack's role in the Agentic CRM strategy is rising, and margins and shareholder returns are also strong; on the other hand, cRPO has only met guidance for two consecutive quarters, current bookings growth has fallen to the mid-single digits, and businesses such as Marketing, Commerce, and Tableau remain weak. The investment view depends on whether the market believes management's guidance for a second-half reacceleration in subscription revenue.
Analysis framework
The report uses reported Q1 metrics, management guidance, cRPO/bookings growth, AI product usage data, margins, free cash flow, and scenario-based valuation as its analytical framework, and cross-validates Agentforce adoption signals against traditional leading SaaS indicators.
Methodology notes
Use cRPO, revenue plus cRPO change, billings, and AOV to assess subscription business momentum
The report emphasizes cRPO as the forward-looking growth indicator investors focus on; although management indicated net new AOV was stronger than overall AOV, cRPO not exceeding expectations means AI usage has not yet fully converted into visible subscription growth.
Based on FY29e free cash flow and discounted by about 10% to derive a forward twelve-month valuation
The base case uses about 15x EV/FCF, corresponding to a $287 target price; the bull case uses 18x, corresponding to $445; the bear case uses 10x, corresponding to $145.
Profit, cash flow, and valuation judgments based on Morgan Stanley research models and estimates
The report notes that, unless otherwise specified, metrics are based on Morgan Stanley ModelWare, and e denotes Morgan Stanley Research estimates.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Salesforce, Inc. (CRM.N)Core covered name; Morgan Stanley maintains an Overweight rating and a $287 target price.
- Strengths
- Agentforce ARR and usage are growing rapidly, Data 360 and Informatica are advancing synergies, Slack is expanding the AI workflow entry point, margins came in above expectations, and repurchase intensity has increased significantly.
- Weaknesses
- cRPO has only met guidance for two consecutive quarters, current bookings growth is weak, and businesses such as Commerce, Marketing, and Tableau are underperforming.
- Comparison
- The stock trades at about 11x EV/CY27 FCF, which the report believes is at a discount to large software peers; if reacceleration in growth materializes, that discount could narrow.
- Risks
- Failure of second-half subscription growth to accelerate, AI usage not converting into revenue, slowing Data Cloud growth, GenAI investment pressuring margins, weak macro demand, and intensifying competition.
Key data
- Agentforce ARR$1.2 billion; up 205% year over yearGrowth further accelerated from 169% in the previous quarter.
- Agentic Work Units3.8 billion AWUs; up 111% quarter over quarterShows rapid growth in Agentforce usage.
- Token usage28.6 trillion tokens; up 152% quarter over quarterAI workload is expanding rapidly, but gross margin remains stable.
- Q1 cRPO growthup 14% year over year; up 13% year over year in constant currencyAfter excluding about 1 percentage point of FX benefit, it only met management guidance.
- Non-GAAP operating margin34.8%Up 250 basis points year over year and 140 basis points above consensus expectations.
- FY27 non-GAAP operating margin guidance34.3%Although Q1 margin beat expectations, the company maintained full-year guidance, implying limited near-term upside for margins.
- Operating cash flow/free cash flow growth guidance4%–5%Previously 9%–10%; the cut mainly reflects an approximately 5 percentage point headwind from debt issuance related to the ASR.
- Accelerated share repurchase$25 billion ASRDrove an approximately 10% year-over-year decline in total diluted share count.
- Valuationabout 11x EV/CY27 FCFThe report views this valuation as relatively attractive, supporting its positive risk/reward stance.
- Target price scenariosBase case $287; Bear case $145; Bull case $445The base case assumes FY26–FY29 revenue CAGR of about 10% and FY29 operating margin of about 35%.
Impact & implications
For investors, this report supports continuing to view CRM as a software leader with AI reacceleration optionality and valuation recovery potential, but near-term catalysts need to shift from "usage growth" to "improving subscription revenue, cRPO, and bookings growth." If organic constant-currency subscription growth accelerates in the second half as guided, the valuation discount may narrow; if cRPO, Marketing/Commerce, and Tableau remain weak, market confidence in management's execution will come under pressure.
Risks
- cRPO and bookings growth fail to improve, causing the market to doubt second-half subscription revenue reacceleration.
- Marketing, Commerce, Tableau, and other businesses remain weak, dragging on overall growth.
- Data Cloud or Agentforce adoption slows, making the AI-related growth narrative difficult to realize.
- GenAI investment and expanding token usage could pressure margins.
- Macro weakness slows enterprise software spending, pushing revenue growth down to the mid-single digits.
- Informatica's on-premise renewals and license revenue could create quarterly volatility.
- Competing platforms could squeeze demand for CRM front-office applications.
What to watch
- Whether organic constant-currency subscription revenue accelerates in the second half in line with management guidance.
- Whether cRPO, billings, current bookings growth, and net new AOV improve in tandem.
- Whether Agentforce ARR, AWUs, token usage, and number of production customers continue to grow at a high rate.
- Whether Slack MCP users, Slack AWUs, and Headless 360/MCP/API calls expand the commercialization funnel.
- Whether renewals and bookings in Commerce, Marketing, and Tableau stabilize.
- Whether FY27 margin and free cash flow guidance see further revisions.
- After the $25 billion ASR, whether the company continues to expand or accelerate repurchases.
- Whether synergies between Informatica and Data 360 continue to convert into order and revenue growth.